Aurora Kinase B - Pipeline Review, H2 2016 - Overview, Comparative Analysis & Pipeline Products Glance - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Aurora Kinase B - Pipeline Review, H2 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Aurora Kinase B, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Aurora Kinase B and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Mentioned:

  • AbbVie Inc
  • Advenchen Laboratories LLC
  • Aeterna Zentaris Inc
  • Amgen Inc
  • Astex Pharmaceuticals Inc
  • AstraZeneca Plc
  • Chipscreen Biosciences Ltd
  • Cielo Therapeutics Inc
  • Merck KGaA
  • Nemucore Medical Innovations Inc
  • Sanofi
  • Sareum Holdings Plc
  • Vertex Pharmaceuticals Inc
  • Vichem Chemie Research Ltd

Key Topics Covered:

  1. Introduction
  2. Aurora Kinase B Overview
  3. Therapeutics Development
  4. Pipeline Products for Aurora Kinase B - Overview
  5. Pipeline Products for Aurora Kinase B - Comparative Analysis
  6. Aurora Kinase B - Therapeutics under Development by Companies
  7. Aurora Kinase B - Therapeutics under Investigation by Universities/Institutes
  8. Aurora Kinase B - Pipeline Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Aurora Kinase B - Products under Development by Companies
  13. Aurora Kinase B - Products under Investigation by Universities/Institutes
  14. Aurora Kinase B - Companies Involved in Therapeutics Development

For more information about this report visit http://www.researchandmarkets.com/research/pqrh9t/aurora_kinase_b

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Enzymes

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Enzymes